These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36316236)

  • 1. Benzenesulfonamides with trisubstituted triazole motif as selective carbonic anhydrase I, II, IV, and IX inhibitors.
    Sharma V; Kumar R; Angeli A; Supuran CT; Sharma PK
    Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200391. PubMed ID: 36316236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors.
    Vats L; Kumar R; Bua S; Nocentini A; Gratteri P; Supuran CT; Sharma PK
    Eur J Med Chem; 2019 Dec; 183():111698. PubMed ID: 31539777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors.
    Buza A; Türkeş C; Arslan M; Demir Y; Dincer B; Nixha AR; Beydemir Ş
    Int J Biol Macromol; 2023 Jun; 239():124232. PubMed ID: 37001773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
    Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
    Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity.
    Kumar R; Sharma V; Bua S; Supuran CT; Sharma PK
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1187-1194. PubMed ID: 28891338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors.
    Kumar A; Siwach K; Rom T; Kumar R; Angeli A; Kumar Paul A; Supuran CT; Sharma PK
    Bioorg Chem; 2022 Jun; 123():105764. PubMed ID: 35366582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel 4-functionalized 1,5-diaryl-1,2,3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors.
    Vats L; Sharma V; Angeli A; Kumar R; Supuran CT; Sharma PK
    Eur J Med Chem; 2018 Apr; 150():678-686. PubMed ID: 29571155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors.
    Said MA; Eldehna WM; Nocentini A; Bonardi A; Fahim SH; Bua S; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2020 Jan; 185():111843. PubMed ID: 31718943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase.
    Kakakhan C; Türkeş C; Güleç Ö; Demir Y; Arslan M; Özkemahlı G; Beydemir Ş
    Bioorg Med Chem; 2023 Jan; 77():117111. PubMed ID: 36463726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of 3-benzenesulfonamide-linked 3-hydrazinoisatin derivatives as carbonic anhydrase inhibitors.
    Swain B; Marde VS; Singh P; Angeli A; Khan A; Yaddanapudi VM; Ullah Q; Supuran CT; Arifuddin M
    Arch Pharm (Weinheim); 2024 Jun; 357(6):e2300718. PubMed ID: 38466120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of carbonic anhydrase IX by sulphonylated 1,2,3-triazole incorporated benzenesulphonamides capable of inducing apoptosis.
    Siwach K; Kumar A; Panchal H; Kumar R; Bhardwaj JK; Angeli A; Supuran CT; Sharma PK
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1454-1463. PubMed ID: 35616287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel triazole-sulfonamide bearing pyrimidine moieties with carbonic anhydrase inhibitory action: Design, synthesis, computational and enzyme inhibition studies.
    Manzoor S; Petreni A; Raza MK; Supuran CT; Hoda N
    Bioorg Med Chem Lett; 2021 Sep; 48():128249. PubMed ID: 34237441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibition with a series of novel benzenesulfonamide-triazole conjugates.
    El-Gazzar MG; Nafie NH; Nocentini A; Ghorab MM; Heiba HI; Supuran CT
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1565-1574. PubMed ID: 30274535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Click chemistry-based synthesis of new benzenesulfonamide derivatives bearing triazole ring as selective carbonic anhydrase II inhibitors.
    Ewies EF; Sabry E; Bekheit MS; Fouad MA; Vullo D; Supuran CT
    Drug Dev Res; 2022 Sep; 83(6):1281-1291. PubMed ID: 35706360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1,2,3-triazole chalcone hybrids.
    Singh P; Swain B; Thacker PS; Sigalapalli DK; Purnachander Yadav P; Angeli A; Supuran CT; Arifuddin M
    Bioorg Chem; 2020 Jun; 99():103839. PubMed ID: 32289586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of a new series of 3-functionalised-1-phenyl-1,2,3-triazole sulfamoylbenzamides as carbonic anhydrase I, II, IV and IX inhibitors.
    Swain B; Angeli A; Angapelly S; Thacker PS; Singh P; Supuran CT; Arifuddin M
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1199-1209. PubMed ID: 31237458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII.
    SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK
    Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and in silico insights of novel 1,2,3-triazole benzenesulfonamide derivatives as potential carbonic anhydrase IX and XII inhibitors with promising anticancer activity.
    Abdelhakeem MM; Morcoss MM; Hanna DA; Lamie PF
    Bioorg Chem; 2024 Mar; 144():107154. PubMed ID: 38309003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.